Combination Approaches to Target PD-1 Signaling in Cancer

Cancer remains the second leading cause of death in the US, accounting for 25% of all deaths nationwide. Immunotherapy techniques bolster the immune cells’ ability to target malignant cancer cells and have brought immense improvements in the field of cancer treatments. One important inhibitory prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Emily K., Strazza, Marianne, Mor, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330480/
https://www.ncbi.nlm.nih.gov/pubmed/35911672
http://dx.doi.org/10.3389/fimmu.2022.927265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330480/
https://www.ncbi.nlm.nih.gov/pubmed/35911672
http://dx.doi.org/10.3389/fimmu.2022.927265

Ejemplares similares